SCHEDULE: Perceptive Advisors Discloses 55.4% Stake in Adagio Medical

Perceptive Advisors and Joseph Edelman have filed an amendment reporting a 55.4% beneficial ownership stake in Adagio Medical Holdings, Inc.

Summary

• Perceptive Advisors LLC and Joseph Edelman report a combined beneficial ownership of 15,321,655 shares of Adagio Medical common stock.
• The reported stake represents 55.4% of the company's outstanding common stock.
• The ownership calculation includes 9,876,586 shares of common stock and 5,445,069 shares issuable upon the exercise of warrants.
• The filing is an amendment (Amendment No. 3) to a previously filed Schedule 13G.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure; while it confirms strong institutional support, it is a standard reporting requirement rather than a change in business operations.

Positives

• Significant institutional backing from a specialized life sciences investment firm.
• High level of alignment between the investment manager and the issuer's long-term capital structure.

Negatives

• High concentration of ownership may limit the free float of the company's shares.

Risks

• Concentrated ownership by a single investment group could impact liquidity and market volatility.
• The reliance on warrant exercise for the reported ownership percentage introduces potential dilution factors for other shareholders.

Future Outlook

The filing does not provide specific forward-looking business guidance, as it is a regulatory disclosure of beneficial ownership.

Management Comments

• The reporting persons certify that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that large-scale ownership by specialized life sciences funds like Perceptive Advisors is common in the medical device sector, often signaling long-term conviction in the company's clinical or commercial pipeline.

Comparison to Industry Standards

• Ownership levels exceeding 50% by a single investment firm are considered high, indicating a 'controlled' or 'heavily influenced' status compared to typical diversified institutional holdings.
• The use of warrants to reach majority ownership is a standard practice in biotech and medtech financing to provide capital while managing immediate dilution.

Stakeholder Impact

• Shareholders should note the high concentration of ownership, which may affect voting outcomes and market liquidity.

Next Steps

• Continued monitoring of future 13G or 13D filings for changes in ownership status.

Key Dates

Keywords

Adagio Medical, Perceptive Advisors, Schedule 13G, Institutional Ownership, Biotech Investment, Joseph Edelman